---
title: "Lawmakers Ask Administration to Rethink Rule That Could Curb Imported Medicines from Canada and Ov"
id: "stat-news-0-stat-lawmakers-urge-trump-to-rethink-new-rule-that-could-restrict-imported-meds"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-lawmakers-urge-trump-to-rethink-new-rule-that-could-restrict-imported-meds"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "STAT News"
source_url: "https://www.statnews.com/pharmalot/2026/09/29/lawmakers-urge-trump-rethink-new-rule-that-could-restrict-imported-medicines/?utm_campaign=rss"
published_at: "2026-09-29T20:41:40.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Lawmakers Ask Administration to Rethink Rule That Could Curb Imported Medicines from Canada and Ov
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-lawmakers-urge-trump-to-rethink-new-rule-that-could-restrict-imported-meds
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/pharmalot/2026/09/29/lawmakers-urge-trump-rethink-new-rule-that-could-restrict-imported-medicines/?utm_campaign=rss)
- **Published At:** 2026-09-29T20:41:40.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Congressional lawmakers are urging the Trump administration to reconsider a federal rule scheduled to take effect on Oct. 22 that could create new barriers to **imported medicines** from Canada and other countries. - The pending rule would require medicines mailed from abroad to undergo a customs process that mandates a licensed **customs broker** and a financial guarantee in the form of an **entry bond**, adding cost and administrative burden for individuals receiving prescriptions from abroad. - For years some Americans have obtained drugs from licensed international pharmacies or by traveling to Canada to reduce out‑of‑pocket costs as U.S. prices rose; the new requirements could limit that practice. - Current law generally makes it illegal to import medicines for personal use under most circumstances because many such drugs have not been reviewed by the **FDA** for safety and efficacy; the article notes this legal backdrop. - The story is published behind STAT+ paywall; the publicly available portion summarizes the rule, lawmakers’ concerns, and the broader context of cross‑border drug imports, but the full STAT+ article content was not provided in the source. - Specific details about which lawmakers signed letters, the administration’s response, industry reactions, estimates of affected patient numbers, legal analyses, or implementation guidance were not reported in the available source text. - The source frames the change as an added burden and cost for Americans who have relied on international shipments to reduce prescription drug spending and situates the issue in the long history of cross‑border drug access prompted by rising U.S. prices. - The piece is authored by Ed Silverman and labeled a STAT+ exclusive; readers must subscribe to access the remainder of the reporting and any additional examples, quotations, or data that the full article likely contains.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/pharmalot/2026/09/29/lawmakers-urge-trump-rethink-new-rule-that-could-restrict-imported-medicines/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/pharmalot/2026/09/29/lawmakers-urge-trump-rethink-new-rule-that-could-restrict-imported-medicines/?utm_campaign=rss) [Vaccines](https://www.statnews.com/topic/vaccines/) [research](https://www.statnews.com/topic/research/) [rare diseases](https://www.statnews.com/topic/rare-diseases/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Pharmalot](https://www.statnews.com/category/pharma/pharmalot/) # Lawmakers urge Trump to rethink new rule that could restrict imported meds from Canada and overseas ## The rule goes into effect on Oct. 22 and could pose significant new hurdles for Americans * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/pharmalot/2026/09/29/lawmakers-urge-trump-rethink-new-rule-that-could-restrict-imported-medicines/?utm_campaign=rss) ![Canada drugs](https://www.statnews.com/wp-content/uploads/2019/10/AdobeStock_179924249-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) Sept. 29, 2026 Pharmalot Columnist, Senior Writer ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) 1. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") 2. [](https://x.com/Pharmalot "X") ed.silverman@statnews.com Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning [Pharmalittle newsletter](https://www.statnews.com/signup/pharmalittle/) and the afternoon [Pharmalot newsletter](https://www.statnews.com/signup/pharmalot/). A growing number of congressional lawmakers are urging the Trump administration to rethink a federal rule going into effect next month over concerns it will prevent Americans from obtaining prescription medicines from licensed international pharmacies. The pending [rule](https://www.federalregister.gov/documents/2026/06/24/2026-12669/indefinite-suspension-of-the-de-minimis-exemption-for-mail-shipments-and-new-postal-informal-entry) requires medicines mailed from abroad to go through a customs process that mandates a licensed customs broker and a financial guarantee in the form of an entry bond. This is an added burden — and cost — for Americans who, for years, have been able to receive prescriptions from Canada and other countries with relatively little difficulty as they sought to save money on expensive drugs. Advertisement Indeed, the clamor for imports began two decades ago as prices rose, prompting some Americans to take bus rides to Canada. Under current law, though, it is illegal to import a medicine into the U.S. for personal use under most circumstances because the drugs often have not been approved by the Food and Drug Administration as safe and effective. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug pricing](https://www.statnews.com/topic/drug-pricing/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [Policy](https://www.statnews.com/topic/policy/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/ed-s-avatar-small4-80x80.png) [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) 1. [](https://x.com/Pharmalot "X") 2. 3. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") Pharmalot Columnist, Senior Writer 1. [](https://x.com/Pharmalot "X") 2. 3. [](https://www.linkedin.com/in/edsilverman/ "Linkedin") Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning [Pharmalittle newsletter](https://www.statnews.com/signup/pharmalittle/) and the afternoon [Pharmalot newsletter](https://www.statnews.com/signup/pharmalot/). ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/Pharmalot-Logo-Black-640x111.png) ### Newsletter From the lab to the medicine chest, these are the must-read drug industry updates of the day Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-1135360288-80x80.jpg) [She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned](https://www.statnews.com/2026/09/29/understanding-vaccine-skepticism-in-parents/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/s3___bgmp-arc_arc-feeds_generic-photos_to-arc_Wiggs-_Beam_3-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Beam Therapeutics sues Chinese biotech, VC-backed startup, alleging theft of intellectual property](https://www.statnews.com/2026/09/29/beam-therapeutics-yoltech-serapha-gene-editing-lawsuit/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2278723586-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms](https://www.statnews.com/2026/09/29/healthcare-industry-midterm-elections-analysis/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/stat_8_24-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’](https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/06/GettyImages-2280225436-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event](https://www.statnews.com/2026/09/29/anthropic-joins-arpa-h-clinical-ai-moonshot-health-tech/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/TevaPF_Wordpress_CalendarImage-80x80.jpg) The Next Era of Biosimilars: Rewriting the Playbook Virtual Oct 19 ](https://www.statnews.com/event/next-era-of-biosimilars-rewriting-the-playbook/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/ESMORecap_Wordpress_CalendarImage-80x80.jpg) ESMO 2026: The STAT Recap Virtual Oct 29 ](https://www.statnews.com/event/esmo-2026-the-stat-recap/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/stat_8_24-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once described as obesity medicines for ‘patients,’ GLP-1s are increasingly lifestyle drugs for ‘customers’](https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Grail_Lab-Tour_FrameCaps_50-1-scaled-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA advisory panel endorses Grail blood test for cancer, saying benefits outweigh risks](https://www.statnews.com/2026/09/23/fda-advisory-panel-recommends-approval-grail-galleri-multi-cancer-blood-test/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_404249326-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [UnitedHealth, CVS push back on Medicare plan to curb remote patient monitoring](https://www.statnews.com/2026/09/23/unitedhealth-cvs-pushback-medicare-plan-rpm-abuse/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_127843759-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Momentum is building for a big change to how doctors get paid](https://www.statnews.com/2026/09/24/patients-first-act-congress-moves-on-doctor-pay-medicare-reform/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/osteoporosis-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Drugmakers, biotech VCs show ‘reinvigorated’ interest in osteoporosis treatments](https://www.statnews.com/2026/09/23/biotech-vc-investors-new-opportunity-osteoporosis-treatments/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot September 29, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more ](https://www.statnews.com/pharmalot/2026/09/29/novo-licenses-obesity-pill-from-china-merck-pulls-antibiotic/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot September 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Merck discontinues a crucial antibiotic despite concerns over superbug resistance ](https://www.statnews.com/pharmalot/2026/09/28/merck-discontinues-antibiotic-recarbrio-in-u-s-despite-superbug-concerns/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot September 28, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Pharmalittle: We’re reading about GLP-1s becoming lifestyle drugs, a setback for Merck and Daiichi, and more ](https://www.statnews.com/pharmalot/2026/09/28/glp1-lifestyle-drug-marketing-merck-daiichi-lung-cancer-setback/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot September 25, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic ](https://www.statnews.com/pharmalot/2026/09/25/roche-xofluza-influenza-treatment-agreements/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharmalot Pharmalot September 25, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Up and down the ladder: The latest comings and goings ](https://www.statnews.com/pharmalot/2026/09/25/up-and-down-the-ladder-latest-comings-goings-jobs-pharma-biotech/) By [Ed Silverman](https://www.statnews.com/staff/ed-silverman/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Drugmakers, biotech VCs show 'reinvigorated' interest in osteoporosis treatments ](https://www.statnews.com/2026/09/23/biotech-vc-investors-new-opportunity-osteoporosis-treatments/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: UniQure's gene therapy continues to slow Huntington's progression after four years ](https://www.statnews.com/2026/09/29/uniqure-huntingtons-gene-therapy-slows-disease-progression-four-years/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Once described as obesity medicines for 'patients,' GLP-1s are increasingly lifestyle drugs for 'customers' ](https://www.statnews.com/2026/09/28/glp1-marketing-shift-obesity-medicine-weight-loss-drug/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors? ](https://www.statnews.com/2026/09/23/quorum-hospitals-nonprofit-conversion-increases-debt-load/) By [Tara Bannow](https://www.statnews.com/staff/tara-bannow/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: UnitedHealth, CVS push back on Medicare plan to curb remo
## Related Clinical Research

- [Law Must Address 340B Treatment of Orphan-Designated Drugs Used for Multiple Conditions](https://medichelpline.com/clinical-feed/stat-news-1-opinion-the-law-has-to-catch-up-on-orphan-designated-drugs-with-multiple-uses.md)
- [Regulation of Kratom and 7-OH: Experts Call for Action and Debate Solutions](https://medichelpline.com/clinical-feed/stat-news-1-kratom-and-7-oh-should-be-regulated-experts-agree-they-re-split-on-how.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [High-Fiber Diet Outperforms Metformin in Blood Sugar Control and Weight Loss](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fiber-diet-vs-metformin-which-is-better-for-blood-sugar-control-weight-loss.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.